OSE IMMUNOTHERAPEUTICS |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.35 EUR | +15.01% |
|
+12.08% | +95.09% |
| 09:53am | OSE: agreement extended with Boehringer Ingelheim, share price rises | CF |
| 04-17 | OSE: licensing agreement with AbbVie enters into force | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 171M | - | |||||
| 55.07B | - | |||||
| 40.22B | ||||||
| 41.79B | ||||||
| 28.17B | ||||||
| 26.28B |
